ROSEN, A TOP-RANKED LAW FIRM, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ITGR

ROSEN, A TOP-RANKED LAW FIRM, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ITGR GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR) […]

ReconAfrica Announces Adoption of Shareholder Rights Plan

(TSX-V:RECO),(OTC US:RECAF),(Other OTC:RECAF),(Boerse Frankfurt – Freiverkehr:0XD), CALGARY, Alberta, Jan. 09, 2026 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that the Board of Directors of the Company has adopted a Shareholder Rights Plan with Odyssey Trust Company as Rights Agent effective today. The Shareholder

SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP

(NASDAQ:SLNO), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE

Class Action Lawsuit Reminder from Pomerantz LLP for Investors of Telix Pharmaceuticals Limited – TLX

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

ReconAfrica Announces Adoption of Shareholder Rights Plan

ReconAfrica Announces Adoption of Shareholder Rights Plan GlobeNewswire January 09, 2026 CALGARY, Alberta, Jan. 09, 2026 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that the Board of Directors of the Company has adopted a Shareholder Rights Plan with Odyssey Trust Company as Rights

SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP

SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company's and/or members of its senior management's possible violation

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Gauzy Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GAUZ

(NasdaqGM:GAUZ), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025, both dates inclusive (the “Class Period”), of the important February 6, 2026 lead plaintiff deadline. SO WHAT: If you

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Gauzy Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GAUZ

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Gauzy Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GAUZ GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025

Fannin Partners Awarded $300K Phase I SBIR Grant from the National Eye Institute to Advance First-in-Class Non-VEGF-Targeted Therapeutics for Wet AMD

Fannin Partners has been awarded a $300,000 Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute (NEI) to advance a first-in-class, non-VEGF-targeted therapeutic for wet age-related macular degeneration (wet AMD), targeting a disease-selective angiogenic pathway in patients who fail to benefit from standard anti-VEGF therapy. Fannin Partners has been awarded a

Highlander Silver and Bear Creek Mining Enter into an Amended and Restated Arrangement Agreement to Remove Highlander Silver Shareholder Approval Requirement

All monetary amounts are expressed in Canadian dollars, unless otherwise indicated. Toronto, Ontario–(Newsfile Corp. – January 9, 2026) – Highlander Silver Corp. (TSX: HSLV) (“Highlander Silver”) and Bear Creek Mining Corporation (TSXV: BCM) (OTCQX: BCEKF) (BVL: BCM) (“Bear Creek”) announce today that they have entered into an amended and restated arrangement agreement dated January 9,

Scroll to Top